This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh ...

The FDA also posted separate warning letters to manufacturers of the so-called GLP-1 drugs, taking issue with a 2024 infomercial featuring Oprah ... ad from the company touted the benefits of its ...

A higher weekly dose of Wegovy achieves even greater weight loss than the standard amount, but this comes with a greater risk of side effects, according to trial results. Prior studies have shown ...

VIENNA — Exercise to maintain weight loss reduced atherosclerosis progression and improved cardiovascular biomarkers, while GLP-1 therapy alone didn’t, according to a randomized trial in people with ...